Trial Profile
A Phase 1, Randomized, Dose Escalation, Single Center, Safety and Pharmacokinetic Study of Single and Multi-Dose, Orally Administered OLT1177 Capsules in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Dec 2017
Price :
$35
*
At a glance
- Drugs Dapansutrile (Primary)
- Indications Inflammation; Musculoskeletal pain
- Focus Adverse reactions
- Sponsors Olatec Industries
- 05 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 14 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 14 May 2014 New trial record